PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

HMSOM researchers: Data shows clinical trials becoming more inclusive

HMSOM researchers: Data shows clinical trials becoming more inclusive
2024-02-02
(Press-News.org) Clinical trials and medical research have been historically lacking in diversity among all groups.

But recent trends have been turning the tide at least a little bit toward equity and inclusivity, according to a new meta-analysis published by a team of investigators from the Hackensack Meridian School of Medicine (HMSOM) and the Hackensack Meridian Health Research Institute (HMHRI).

The meta-analysis of clinical trials which included New Jersey patients from 2017 to 2022 show a snapshot of more diverse representation - and better reporting of race and ethnicity factors, according to the new paper in the Elsevier journal Global Epidemiology.

“The past five years have seen an overall uptick in the equity of race/ethnicity reporting and inclusivity of clinical trials, as compared to previously reported data, presaging the potential acquisition of ever more powerful and meaningful results of such intervention studies going forward,” write the authors, including three HMSOM students.

The team used the Clinicaltrials.gov registry to identify nearly 500 clinical trials which took place at least in part in New Jersey.

Of this group of trials, greater than 97 percent reported on race and/or the ethnicity of the enrollees, according to the findings. The participation in the trials assessed collectively still showed a majority 76.7 percent White participants; but the Black participants made up about 14.1 percent of the enrollees, which is slightly higher than the 2020 U.S. Census figure (which was used as a reference standard.)

The proportion of Asian and Hispanic descent, however, was slightly lower than the corresponding Census figures.

Thus, more inclusivity work needs to be done, according to the authors.

“Our 5-year snapshot reveals that a very large percentage of trials report on race/ethnicity - and inclusivity is improving,” the authors conclude. “While there is still some way to go to have the demographic numbers in these trials match U.S. Census values, our results suggest that recent efforts are having an effect.”

END

[Attachments] See images for this press release:
HMSOM researchers: Data shows clinical trials becoming more inclusive

ELSE PRESS RELEASES FROM THIS DATE:

CAR T cells show promise against age-related diseases in mice

CAR T cells show promise against age-related diseases in mice
2024-02-02
Highlights Laboratory research led by MSK and Cold Spring Harbor Laboratory demonstrates the potential for CAR T cells to improve “healthspan” by eliminating senescent cells associated with aging-related diseases. Not only was the treatment able to improve the metabolic function of aging mice and mice fed a high-fat diet, but it also proved protective against metabolic decline when given to younger mice. The CAR T cell-based approach offers a powerful alternative to more traditional small-molecule drugs target senescent cells, supported by its long-lasting effects and the potential to fine-tune ...

Clinique partners with Icahn School of Medicine at Mount Sinai to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

Clinique partners with Icahn School of Medicine at Mount Sinai to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center
2024-02-02
New York, NY (February 2, 2024) – Clinique and Icahn School of Medicine at Mount Sinai today announced a philanthropic partnership to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center. The Center will develop forward-thinking research in dermatology, exploring the biological underpinnings of how skin ages, skin allergies and inflammatory or eczematous skin conditions, including eczema (or atopic dermatitis) and contact dermatitis. Rooted in a shared mission to conduct dermatological research that improves patients’ lives, the partnership will focus on applicable scientific discovery and leading-edge innovation to modernize allergy science in order to ...

Strategies for enhancing the performance of nickel single-atom catalysts for the electroreduction of CO2 to CO

Strategies for enhancing the performance of nickel single-atom catalysts for the electroreduction of CO2 to CO
2024-02-02
Electrocatalytic reduction of carbon dioxide (CO2) is considered as an effective strategy for mitigating the energy crisis and the greenhouse effect. Among the multiple reduction products, CO is regarded as having the highest market value as it is a crucial feedstock for Fischer-Tropsch process which can synthesize high-value long-chain hydrocarbons. Since the carbon dioxide reduction reaction (CO2RR) has complex intermediates and multiple proton-coupled electron transfer processes, improving the reaction activity and products selectivity remain two great challenges. Single-atom catalysts (SACs) have the advantages of high atom utilization, tunable coordination structure ...

Brexit-induced spatial restrictions reveal alarming increase of fishing fleet’s carbon footprint

Brexit-induced spatial restrictions reveal alarming increase of fishing fleet’s carbon footprint
2024-02-02
In a study published today in Marine Policy, researchers have unveiled striking evidence that fisheries management decisions such as spatial fisheries restrictions can increase greenhouse gas emissions. The study, conducted by a team of scientists led by postdoctoral researcher Kim Scherrer at the University of Bergen, sheds light on the unforeseen consequences of policy changes on fishing fleets and their carbon footprint. In the North Atlantic, international agreements often allow fleets to follow the fish across national borders. This allows fishers to catch the fish where it is most efficient. But when the UK left the EU (Brexit), ...

Scammed! Animals ‘led by the nose’ to leave plants alone

Scammed! Animals ‘led by the nose’ to leave plants alone
2024-02-02
University of Sydney researchers have shown it is possible to shield plants from the hungry maws of herbivorous mammals by fooling them with the smell of a variety they typically avoid. Findings from the study published in Nature Ecology & Evolution show tree seedlings planted next to the decoy smell solution were 20 times less likely to be eaten by animals. “This is equivalent to the seedlings being surrounded by actual plants that are unpalatable to the herbivore. In most cases it does trick the animals into leaving the plants alone,” said PhD student Patrick ...

Why are people climate change deniers?

Why are people climate change deniers?
2024-02-02
Do climate change deniers bend the facts to avoid having to modify their environmentally harmful behavior? Researchers from the University of Bonn and the Institute of Labor Economics (IZA) ran an online experiment involving 4,000 US adults, and found no evidence to support this idea. The authors of the study were themselves surprised by the results. Whether they are good or bad news for the fight against global heating remains to be seen. The study is being published in the journal Nature Climate Change. STRICTLY EMBARGOED: Do not publish before Friday, February 02, 11 a.m. CET! A surprisingly large number of people ...

Epigenetic status determines metastasis

2024-02-02
Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University investigated in mice how spreading tumor cells behave at the site of metastasis: Some tumor cells immediately start to form metastases. Others leave the blood vessel and may then enter a long period of dormancy. What determines which path the cancer cells take is their epigenetic status. This was also confirmed in experiments with human tumor cells. The results of the study could pave the way for novel diagnostic and therapeutic applications. What makes cancer so dangerous? ...

Prehistoric mobility among Tibetan farmers, herders shaped highland settlement patterns, cultural interaction, study finds

Prehistoric mobility among Tibetan farmers, herders shaped highland settlement patterns, cultural interaction, study finds
2024-02-02
The 1 million-square-mile Tibetan Plateau — often called the “roof of the world” — is the highest landmass in the world, averaging 14,000 feet in altitude. Despite the extreme environment, humans have been permanent inhabitants there since prehistoric times. Farming and herding play major roles in the economy of the Tibetan Plateau today — as they have throughout history. To make the most of a difficult environment, farmers, agropastoralists and mobile herders interact and move in conjunction with one another, which in turn shapes ...

World Wetlands Day: Bogs hold an important key to the climate crisis

2024-02-02
World Wetlands Day: Bogs hold an important key to the climate crisis Peat bogs store twice as much CO2 as all of the world's forests combined. A new research center at the University of Copenhagen will map Earth’s wetlands and provide important knowledge about the greenhouse gas budgets of these areas. The Global Wetland Center will teach us how to contain carbon from plants and trees in bogs and other wetlands – and preserve it as well as the ancient bog bodies also found there. He is world-renowned ...

Natural therapy shows promise for dry-eye disease

2024-02-02
Researchers at the University of Auckland are running a trial of castor oil as a potential safe and natural treatment for dry-eye disease following a successful pilot study. While exact figures aren’t available for New Zealand, in Australia, it is estimated dry-eye disease affects around 58 percent of the population aged over 50. Advancing age, menopause, increased screen time, contact lens wear are just some of the risk factors for developing dry eye disease. Blepharitis is the most common cause of dry-eye disease, accounting for more than 80 percent of cases. It is a chronic condition with no known cure. “Currently, patients ...

LAST 30 PRESS RELEASES:

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

[Press-News.org] HMSOM researchers: Data shows clinical trials becoming more inclusive